Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216

Morag Shaw (Lead / Corresponding author), Philip Cohen, Dario R. Alessi

Research output: Contribution to journalArticlepeer-review

208 Citations (Scopus)

Abstract

293 cells were transfected with wild-type GSK3β (WT-GSK3β) or a mutant in which the PKB phosphorylation site (Ser-9) was altered to Ala (A9-GSK3β). Upon stimulation with IGF-1 or insulin, WT-GSK3β was inhibited 75% or 60%, respectively, whereas the activity of the A9-GSK3β mutant was unaffected. Incubation of WT-GSK3β with PP2A1 (a Ser/Thr-specific phosphatase) completely reversed the IGF-1- or insulin-induced inhibition. IGF-1 stimulation did not induce any tyrosine dephosphorylation of WT-GSK3β or A9-GSK3β. Coexpression of WT-GSK3β in 293 cells with either PKBα (also known as AKT) or PDK1 (the 'upstream' activator of PKB) mimicked the IGF-1- or insulin-induced phosphorylation of Ser-9 and inactivation of GSK3β.

Original languageEnglish
Pages (from-to)307-311
Number of pages5
JournalFEBS Letters
Volume416
Issue number3
DOIs
Publication statusPublished - 27 Oct 1997

Keywords

  • 3-Phosphoinositide-dependent protein kinase
  • Glycogen synthase
  • Glycogen synthase kinase-3
  • Insulin
  • Insulin-like growth factor-1
  • Protein kinase B

Fingerprint Dive into the research topics of 'Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216'. Together they form a unique fingerprint.

Cite this